Then they compared those patients to others who stayed on their antidepressant drug, switched to a newdrug, or had another drug added to their original medication - but didn't have any talk therapy.
Asked a panel of scientists and doctors to predict regulatory decisions and newdrug sales using Crowdcast, and they were more accurate than the company's original prediction 86 percent of the time.